A phase III study of adjuvant gangloside vaccination (GM2-KLM/QS-21) [melanoma vaccine] therapy vs. high-dose interferon alpha-2b (Intron A) for high-risk melanoma T4 greater than 4mm primary or regional lymph node metastasis
Latest Information Update: 01 Dec 2005
At a glance
- Drugs Interferon alpha-2b (Primary) ; Melanoma vaccine (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 01 Dec 2005 New trial record.